Global Abdominal Aortic Aneurysm Treatment Market Size By Treatment (Open Surgery, Medication, Antihypertensive), By End-User (Hospital, Clinics), By Geographic Scope And Forecast

Abdominal Aortic Aneurysm Treatment Market Size And Forecast

Abdominal Aortic Aneurysm Treatment Market size was valued at USD 2.08 Billion in 2023 and is projected to reach USD 3.23 Billion by 2031, growing at a CAGR of 6.27% from 2024 to 2031.

• Abdominal aortic aneurysm (AAA) treatment refers to medical measures targeted at treating a condition characterized by dilatation or bulging of the abdominal aorta, which can cause life-threatening complications if ruptured. Small aneurysms can be monitored, but bigger or symptomatic aneurysms can be treated using minimally invasive endovascular aneurysm repair (EVAR) or open surgery. These treatments are adapted to the aneurysm’s size, growth rate, and the patient’s overall health, with an emphasis on preventing rupture and treating symptoms.
• AAA treatment appears hopeful, thanks to advances in technology and procedures. 3D modeling and better ultrasound procedures are examples of imaging technology innovations that help diagnosis and treatment planning.
• The creation of biocompatible materials for stents and grafts is intended to improve the long-term outcomes of endovascular treatments. Ongoing research into the genetic and molecular mechanisms that influence aneurysm formation may lead to more tailored treatment techniques in the future years, improving patient care and outcomes.

>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=123303

To Get Detailed Analysis: Download Report PDF

Global Abdominal Aortic Aneurysm Treatment Market Dynamics

The key market dynamics that are shaping the global Abdominal Aortic Aneurysm Treatment Market include:

Key Market Drivers:

• Advancements in Minimally Invasive Surgical Techniques: Advances in less invasive surgical procedures, particularly endovascular aneurysm repair (EVAR), have drastically altered the treatment of abdominal aortic aneurysms. A study published in the Journal of Vascular Surgery found that EVAR operations increased from 5.2% of Abdominal Aortic Aneurysm Treatment (AAA) repairs in 2000 to 74% by 2010. According to the National Institute for Health and Care Excellence (NICE) in the UK, EVAR is now used in more than 70% of elective AAA repairs, indicating a high preference for these procedures. This transition is being driven by variables such as faster recovery periods, fewer problems, and shorter hospital stays, making EVAR a more enticing option for both patients and healthcare professionals.
• Increasing Prevalence of Abdominal Aortic Aneurysms: The rising prevalence of abdominal aortic aneurysms (AAAs) is a major driver in the treatment market. According to the Society for Vascular Surgery, approximately one in every twenty people in the United States may acquire a AAA over their lifetime, and the CDC reported 9,923 fatalities caused by AAA in 2018, with men accounting for the majority of the cases. As the population ages, the prevalence of AAAs is predicted to rise, increasing the need for appropriate treatment alternatives. This trend is fueled by the aging population’s increased risk factors, such as hypertension and atherosclerosis, which necessitate increasingly extensive medical interventions.
• Aging Population and Associated Risk Factors: The global aging population has a substantial impact on the abdominal aortic aneurysm (AAA) treatment market. The World Health Organization (WHO) predicts that by 2050, the proportion of adults over 60 will nearly double, from 12% to 22%. The National Institute on Aging predicts that the number of Americans aged 65 and older will increase from 52 million in 2018 to 95 million in 2060. As the risk of AAA rises with age, this demographic trend is predicted to significantly boost demand for AAA treatments. This increase is driven by a larger frequency of age-related risk factors, such as cardiovascular disease, which necessitates additional healthcare interventions for this vulnerable demographic.

Key Challenges:

• High Surgical Risks: Abdominal aortic aneurysm (AAA) treatments, especially open surgical repair, carry major hazards such as bleeding, infection, and organ damage. These hazards can prevent patients from seeking treatment, resulting in increased healthcare expenses due to longer hospital stays or reoperations. The fear of these potential effects influences patient compliance and decision-making.
• Cost of Treatment: The high costs of AAA treatments, like as surgical procedures and post-operative care, can be prohibitive for individuals and healthcare systems. Inadequate insurance coverage for specific operations, particularly for less prevalent therapies, might restrict access for patients, particularly those without complete health insurance.
• Variability in Treatment Guidelines: Disparities in clinical standards and recommendations between healthcare practitioners might result in discrepancies in patient care. These distinctions might lead to uncertainty and unwillingness to adopt novel treatment approaches, thereby jeopardizing patient results. Standardized treatment protocols are vital for ensuring that all patients receive the best possible care.
• Aging Population with Comorbidities: As the population ages, more AAA patients develop comorbidities such as diabetes, hypertension, and cardiovascular disease. These additional health difficulties can complicate treatment options and raise surgical risks, making it more difficult to obtain positive results. This intricacy needs a more nuanced approach to patient care.

Key Trends:

• Advancement in Imaging Technologies: High-resolution ultrasound and 3D CT scans are improving AAA identification and monitoring. These tools enable more accurate assessments of aneurysm size and form, resulting in better treatment planning. Increased diagnostic accuracy encourages early intervention, which can lead to better patient outcomes and lower total healthcare expenditures.
• Increased Research and Development Funding: Growing investment in AAA treatment research and development is resulting in technological and technique advances. Both the public and corporate sectors are providing funding for research into new therapeutic techniques and ways to improve existing treatments. This tendency promotes innovation and broadens the alternatives available to physicians and patients, ultimately improving treatment quality.
• Emergence of Telemedicine: The emergence of telemedicine has revolutionized patient management in the AAA treatment market. Remote consultations and follow-ups give patients convenient access to specialists, especially in disadvantaged areas. This trend promotes patient participation and compliance while also lowering obstacles to care, resulting in improved treatment accessibility and outcomes.
• Focus on Multidisciplinary Care Teams: The value of multidisciplinary care teams in AAA management is becoming more widely recognized. Collaboration between vascular surgeons, radiologists, and cardiologists ensures comprehensive patient care and appropriate treatment options. This trend improves patient outcomes by advocating comprehensive treatments and tackling the complexity of AAA treatment.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=123303

Global Abdominal Aortic Aneurysm Treatment Market Regional Analysis

Here is a more detailed regional analysis of the global Abdominal Aortic Aneurysm Treatment Market:

North America:

• North America dominates the Abdominal Aortic Aneurysm (AAA) treatment market, owing to a strong healthcare infrastructure, high AAA prevalence, and a network of trained medical specialists. The Centers for Disease Control and Prevention (CDC) estimated that AAA caused 9,923 deaths in the US in 2018, with men accounting for 58% of these fatalities. With nearly one in every twenty Americans having a AAA over their lifetime, the healthcare system faces a substantial burden. The aging population is an essential factor, with the US Census Bureau forecasting that 73 million people will be over 65 by 2030, increasing the risk of AAA, which is most common among older adults.
• Advances in therapeutic procedures have significantly improved results for AAA patients. According to a study published in the Journal of Vascular Surgery, endovascular aneurysm repair (EVAR) procedures increased from 5.2% in 2000 to 74% by 2010. Enhanced screening programs, such as those proposed by the United States Preventive Services Task Force for men aged 65 to 75 who had smoked, could avoid around 2,000 AAA-related deaths each year.
• The economic impact is substantial, with AAA repair costs topping USD 1.2 Billion in 2019. Continued research investment, estimated by the National Institutes of Health at more than USD 35 Million in 2020, is supporting innovation in treatment modalities, cementing North America’s strong position in the global AAA therapy market.

Asia Pacific:

• The Asia-Pacific abdominal aortic aneurysm (AAA) treatment market is growing rapidly owing to increased knowledge of the ailment, improvements in healthcare infrastructure, rising disposable incomes, and an aging population. The transition to minimally invasive techniques, particularly Endovascular Aneurysm Repair (EVAR), is remarkable for its benefits, including less surgical trauma and faster recovery times. According to a study published in the Journal of Vascular Surgery, the prevalence of AAA among Asian populations ranges from 0.5% to 1.8%, which, while lower than in Western nations, still represents a significant number of cases given the huge population.
• The elderly demographic in Asia-Pacific is a key driver of market growth. The United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) predicts that the number of people aged 65 and over will more than double from 395 million in 2020 to 883 million by 2050, increasing the prevalence of AAA because age is a main risk factor.
• The rising acceptance of EVAR, which increased from 28% to 60% in Asian countries between 2005 and 2015, as well as a 15% annual increase in Japan and a 25% increase in hospitals offering EVAR in China, highlight the market’s rapid growth. These developments are propelling the AAA treatment market forward, showing a considerable opportunity for further growth in the coming years.

Global Abdominal Aortic Aneurysm Treatment Market: Segmentation Analysis

The Global Abdominal Aortic Aneurysm Treatment Market is Segmented on the basis of Treatment, End-User, And Geography.

Abdominal Aortic Aneurysm Treatment Market, By Treatment

• Open Surgery
• Endovascular Aneurysm Repair
• Medication
• Antihypertensive
• Antilipidemics

Based on Treatment, The market is Segmented into Open Surgery, Endovascular Aneurysm Repair, Medication, Antihypertensive, and Antilipidemics. Endovascular Aneurysm Repair (EVAR) is the dominant segment due to its minimally invasive method, which leads to shorter recovery times and lower complication rates than standard open surgery. This approach has been the preferred choice for many patients and healthcare providers, resulting in widespread acceptance. The Medication sector, which includes antihypertensive and antilipidemic drugs, is the fastest expanding. This increase can be related to increased awareness of controlling risk factors associated with AAA, as healthcare professionals recognize the value of pharmaceutical therapies in stabilizing aneurysm growth and improving patient outcomes.

Abdominal Aortic Aneurysm Treatment Market, By End-User

• Hospitals
• Clinics

Based on End-User, The market is segmented into Hospitals and Clinics. Hospitals are the market leaders due to their extensive resources, advanced surgical skills, and access to expert medical teams. Hospitals often manage more difficult cases and provide a broader range of treatment choices, such as surgical procedures and post-operative care, making them the preferred choice for AAA therapy. Clinics are the fastest expanding segment, owing to rising demand for outpatient operations and preventive care. As more patients seek convenient healthcare solutions for initial evaluations and follow-up treatments, clinics are expanding their services, particularly in non-invasive choices, making them an appealing alternative in the AAA treatment environment.

Abdominal Aortic Aneurysm Treatment Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, The Global Abdominal Aortic Aneurysm Treatment Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America currently leads the abdominal aortic aneurysm (AAA) treatment market due to its advanced healthcare infrastructure, high prevalence of AAA, and established medical competence. The Asia-Pacific area is having the highest development, owing to increased knowledge about AAA, improved healthcare services, and a growing aging population. This region is also seeing an increase in the use of minimally invasive techniques such as Endovascular Aneurysm Repair (EVAR), which has advantages in terms of lower surgical trauma and faster recovery times.

Key Players

The “Global Abdominal Aortic Aneurysm Treatment Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Lombard Medical, Inc., L.Gore & Associates, Endologix, Inc., Medtronic, Cardinal, Terumo Corporation, Jotec Gmbh, Cook Medical, Inc., and Cvt Surgical Center. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Abdominal Aortic Aneurysm Treatment Market Recent Developments

• In April 2021, Cardinal Health launched Outcomes™, a digital ecosystem that connects pharmacists, payers, and pharmaceutical businesses to reduce medication non-adherence. Outcomes offer digital health solutions such as tailored drug delivery, digital patient engagement, and telepharmacy via its Connect™ platform.
• In July 2020, Novartis started an initiative to make COVID-19 therapies more affordable for low-income countries. The project comprises 15 Sandoz medicines for respiratory difficulties and septic shock.

Report Scope

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.